Tivic Health (TIVC) Systems announced that its Board of Directors has appointed Michael Handley as CEO of Tivic, effective immediately. Mr. Handley succeeds Jennifer Ernst, who has served as CEO since its founding in 2016 and is stepping down from the CEO role as the Company enters its next chapter. Ms. Ernst will continue to support the Company through this strategic transition. Mr. Handley brings over two decades of executive leadership in the biopharmaceutical and medical device industries
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIVC:
- Tivic Health schedules follow-up meeting with BARDA for entolimod
- Tivic Health Establishes Flexible $50 Million Equity Line
- Tivic Health, BARDA discuss entolimod for acute radiation syndrome
- Tivic Health Highlights TLR5 Pipeline in New Investor Presentation
- Tivic Health delivers 200x scale-up in manufacturing for entolimod